Journal of Preventive Cardiology
spacer
Current Issue

Original Article

Year: 2017 I  Volume: 6I  Issue: 3I  Pages: 1043–1047
 

Discontinuation practices of anti-platelet drugs in the peri-operative period and their outcomes on patient care

Renuka P Munshi, DNB Clinical Pharmacology; Sarayu A Pai, M.Pharm

Dept. of Clinical Pharmacology, T N Medical College and BYL Nair Charitable Hospital, Dr A.L. Nair Road, Mumbai Central (E), Mumbai-400 008

 

Abstract

Background : The current study aimed to determine the discontinuation pattern of anti-platelet drugs in the peri-operative period and study the outcomes.

Methods : A retrospective cohort analysis of data of patients receiving anti-platelet drugs, who had also undergone cardiac interventions over one year from January 2014 to December 2014, was analysed. Informed consent waiver was obtained from the Institutional Ethics Committee. Six hundred and fifty case files of patients with coronary artery disease (CAD), who had undergone elective or emergent cardiac surgeries and were receiving anti-platelet drugs in the peri-operative period, were reviewed.

Results : Two hundred and ninety-one patients were diagnosed with CAD, six had history of cerebrovascular event/s and eight had congestive cardiac failure. One hundred and forty two patients underwent coronary artery bypass surgery while 508 underwent a cardiac procedure. None of the anti-platelet drugs were withdrawn in the peri-operative period as per patient records. Two hundred and two patients did not have any bleeding in the post-operative period, two patients had diffuse bleeding following the procedure, and 446 patients had localized surgical site bleeding. Two patients experienced acute coronary syndrome, whereas 18 had peripheral arterial thrombosis.

Conclusions : The study results showed that documentation practices in our hospital should be urgently improved. Although patients were verbally informed regarding the need to discontinue oral anti-platelet agents, documentation of the same was missing in the case files. Absence of major adverse events in the peri-operative period was the only indicator that discontinuation instructions were given and complied with by the patients.

 
Keywords
Anti-platelet drugs
Discontinuation practices
Cardiac interventions
Peri-operative [eriod
Complications
 
[Full Text]
Print this Article
Back to main page
Slideshow
  • Original Article
    Coronary artery disease risk factors distribution in cities versus urban and rural population of Karnataka
    -Dr Rajith KS*
    abstract text full text
  • Review Article
    Interventions to improve medication adherence in heart failure—A systematic review
    -Roberta L Fulton*, RGN, MSc; Thilo KroIl
    abstract text full text
  • Updates on Statins
    full text
  • News and Views
     
    full text
  • Forthcoming Events
     
    full text
spacer
Slideshow
  • American Society of Hypertension Annual Meeting 2017 (ASH 2017)
    To be held on Sep 13-16, 2017, San Francisco
    Read more...
  • American Society of Nuclear Cardiology 22nd Annual Scientific Session 2017 (ASNC 2017)
    To be held on Sep 14-17, 2017, Kansas City
    Read more...
  • Heart Failure Society of America 21st Annual Scientific Meeting 2017 (HFSA 2017)
    To be held on Sep 16-19, 2017, Texas
    Read more...
  • Global Cardio Diabetes Conclave 2017 (GCDC 2017)
    To be held on Sep 29—Oct 01, 2017, Chennai
    Read more...
Journal of Preventive Cardiology
spacer
 
spacer
Print ISSN: 2249-4308
Online ISSN: 2277-6559
 
Frequency: Quarterly
 
 
Email This
close
 
 
  [ Separate multiple email addresses with commas (Limit is 10). ]